IBA(1g/kg) - search results

Ireland - English - HPRA (Health Products Regulatory Authority)

eptifibatide strides 0.75 mg/ml solution for infusion

generics (uk) limited - eptifibatide - solution for infusion - 0.75 mg/ml - platelet aggregation inhibitors excl. heparin

Ireland - English - HPRA (Health Products Regulatory Authority)

eptifibatide strides 2 mg/ml solution for injection

generics (uk) limited - eptifibatide - solution for injection - 2 mg/ml - platelet aggregation inhibitors excl. heparin

New Zealand - English - Medsafe (Medicines Safety Authority)

eptifibatide viatris

viatris limited - eptifibatide 0.75 mg/ml (75 mg in 100 ml) - solution for infusion - 0.75 mg/ml - active: eptifibatide 0.75 mg/ml (75 mg in 100 ml) excipient: citric acid monohydrate sodium hydroxide water for injection - indicated for patients undergoing non-urgent, percutaneous coronary intervention (pci) with coronary stenting for the reduction of death, myocardial infarction, urgent revascularisation and the need for acute antithrombotic rescue therapy. indicated for the reduction of death and myocardial infarction in patients presenting with unstable angina or non-q-wave myocardial infarction. indicated in patients who are managed with standard medical therapies and/or with percutaneous coronary intervention. eptifibatide is intended for use with aspirin, heparin or clopidigrel.

New Zealand - English - Medsafe (Medicines Safety Authority)

eptifibatide viatris

viatris limited - eptifibatide 2 mg/ml (20 mg in 10 ml) - solution for injection - 2 mg/ml - active: eptifibatide 2 mg/ml (20 mg in 10 ml) excipient: citric acid monohydrate sodium hydroxide water for injection - indicated for patients undergoing non-urgent, percutaneous coronary intervention (pci) with coronary stenting for the reduction of death, myocardial infarction, urgent revascularisation and the need for acute antithrombotic rescue therapy. indicated for the reduction of death and myocardial infarction in patients presenting with unstable angina or non-q-wave myocardial infarction. indicated in patients who are managed with standard medical therapies and/or with percutaneous coronary intervention. eptifibatide is intended for use with aspirin, heparin or clopidigrel.